Sponsor pipeline

Lexeo Therapeutics clinical trial pipeline

Get alerts when Lexeo Therapeutics's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 1
1
Phase 1/2
2
Phase 2
1
Not charted: 3 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT07721025 Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy Friedreich Ataxia Recruiting 2026-09-02
Phase 1/2
NCT05445323 Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia Friedreich Ataxia Active, Not Recruiting 2025-12-23
NCT06109181 Gene Therapy for ACM Due to a PKP2 Pathogenic Variant Arrhythmogenic Cardiomyopathy Active, Not Recruiting 2025-11-12
Phase 1
NCT05400330 Long-Term Follow-up of Gene Therapy for APOE4 Homozygote Alzheimer's Disease Alzheimer Disease Active, Not Recruiting 2025-07-01
Not specified
NCT06865482 Clinical Course Of Disease In Participants With FA-CM Friedreich Ataxia Recruiting 2026-09-02
NCT06976606 A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic… Arrhythmogenic Cardiomyopathy Recruiting 2025-05-16
NCT07050160 Long-term Follow-up Study of Gene Therapy for Arrhythmogenic Cardiomyopathy Due to a… Arrhythmogenic Cardiomyopathy Enrolling by Invitation 2025-11-12

Disease areas by active trials

Heart Disease (6) · Alzheimer's Disease (1) · Dementia (1)

Get alerts when Lexeo Therapeutics's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free